Home
About
Mission
Leadership
Research
Discovery Teams
Areas of Focus
Outreach
Drug Discovery Online
Community Outreach
Warren Center Lecture Series
News
Careers
Funding
Contact
Invest
Dec
13
Dec 13
A potential new approach for the treatment of schizophrenia
Guest User
By: Vanderbilt University Research News
Feb 24
Vanderbilt inks collaboration with precision neuroscience company Neumora to continue development of investigational treatment for neuropsychiatric disorders
Sep 28
Jeffrey Conn, founding director of Warren Center for Neuroscience Drug Discovery, named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics